Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May 15;78(20):1548-54.
doi: 10.1212/WNL.0b013e3182563b19. Epub 2012 May 9.

Patterns of treatment response in newly diagnosed epilepsy

Affiliations

Patterns of treatment response in newly diagnosed epilepsy

M J Brodie et al. Neurology. .

Abstract

Objective: To delineate the temporal patterns of outcome and to determine the probability of seizure freedom with successive antiepileptic drug regimens in newly diagnosed epilepsy.

Methods: Patients in whom epilepsy was diagnosed and the first antiepileptic drug prescribed between July 1, 1982, and April 1, 2006, were followed up until March 31, 2008. Outcomes were categorized into 4 patterns: (A) early and sustained seizure freedom; (B) delayed but sustained seizure freedom; (C) fluctuation between periods of seizure freedom and relapse; and (D) seizure freedom never attained. Probability of seizure freedom with successive drug regimens was compared. Seizure freedom was defined as no seizures for ≥1 year.

Results: A total of 1,098 patients were included (median age 32 years, range 9-93). At the last clinic visit, 749 (68%) patients were seizure-free, 678 (62%) on monotherapy. Outcome pattern A was observed in 408 (37%), pattern B in 246 (22%), pattern C in 172 (16%), and pattern D in 272 (25%) patients. There was a higher probability of seizure freedom in patients receiving 1 compared to 2 drug regimens, and 2 compared to 3 regimens (p < 0.001). The difference was greater among patients with symptomatic or cryptogenic than with idiopathic epilepsy. Less than 2% of patients became seizure-free on subsequent regimens but a few did so on their sixth or seventh regimen.

Conclusions: Most patients with newly diagnosed epilepsy had a constant course which could usually be predicted early. The chance of seizure freedom declined with successive drug regimens, most markedly from the first to the third and among patients with localization-related epilepsies.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Patient flow throughout the study in terms of seizure outcome
Seizure-free represents a patient with no seizure for at least the previous 12 months. Pattern A (early and sustained seizure freedom): patients became seizure-free within 6 months of starting treatment and remained seizure-free. Pattern B (delayed and sustained seizure freedom): patients became seizure-free after 6 months of starting treatment and remained seizure-free. Pattern C (fluctuating course): patients fluctuating between periods of seizure freedom and relapse. Pattern D: patients never seizure-free for any complete year.
Figure 2
Figure 2. Cumulative probability of being seizure-free by time from start of treatment and number of antiepileptic drug regimens tried
(A) All patients (n = 1,098; 700 tried 1, 230 tried 2, 100 tried 3, 36 tried 4, and 32 tried 5 or more regimens); (B) patients with idiopathic epilepsies (n = 251; 220 tried 1–2, 31 tried 3 or more regimens); and (C) patients with symptomatic or cryptogenic (nonidiopathic) epilepsies (n = 847; 710 tried 1–2, 137 tried 3 or more regimens).

Comment in

References

    1. Ngugi AK, Kariuki SM, Bottomley C, Kleinschmidt I, Sander JW, Newton CR. Incidence of epilepsy: a systematic review and meta-analysis. Neurology 2011; 77: 1005– 1012 . - PMC - PubMed
    1. Callaghan BC, Anand K, Hesdorffer D, Hauser WA, French JA. Likelihood of seizure remission in an adult population with refractory epilepsy. Ann Neurol 2007; 62: 382– 389 . - PubMed
    1. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007; 62: 375– 381 . - PubMed
    1. Choi H, Heiman G, Pandis D, et al. Seizure remission and relapse in adults with intractable epilepsy: a cohort study. Epilepsia 2008; 49: 1440– 1445 . - PMC - PubMed
    1. Schiller Y. Seizure relapse and development of drug resistance following long-term remission. Arch Neurol 2009; 66: 1233– 1239 . - PubMed

Substances